Esbah, O. Et Al. 2013. Metformin in diabetic pancreatic cancer patients: Benefit or not-Multicenter experience.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Esbah, O., Oksuzoglu, B., Eren, T., Helvaci, K., Guler, T., Duran, A. O., ... Bal, O.(2013). Metformin in diabetic pancreatic cancer patients: Benefit or not-Multicenter experience. . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Esbah, Onur Et Al. "Metformin in diabetic pancreatic cancer patients: Benefit or not-Multicenter experience.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2013

Esbah, Onur Et Al. "Metformin in diabetic pancreatic cancer patients: Benefit or not-Multicenter experience.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2013

Esbah, O. Et Al. (2013) . "Metformin in diabetic pancreatic cancer patients: Benefit or not-Multicenter experience.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={Onur Esbah Et Al. }, title={Metformin in diabetic pancreatic cancer patients: Benefit or not-Multicenter experience.}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2013}}